The General Optical Council (GOC) published findings from its first thematic review into commercial practices and patient safety. The report identifies widespread concerns among registrants regarding stress, burnout, and high patient volumes, noting that students and early-career professionals are particularly affected. While patient satisfaction remains high, the review highlights barriers to accessing eyecare, including a lack of online price transparency and insufficient information on NHS financial support eligibility. It also notes concerns about pressure selling deterring routine sight tests and some businesses not providing tests for young children. The GOC states there is no direct evidence of harm but emphasizes that limited outcome data makes quality assessment difficult. Planned actions include reviewing Standards for Optical Businesses and working with education providers to address these issues.
The German Central Association of Optometrists (ZVA) is calling for more rigorous market surveillance of corrective eyewear imported directly from non-EU countries via international online platforms. While such products fall under the EU Medical Device Regulation (MDR), the ZVA argues that current controls are insufficient compared to the strict requirements imposed on local opticians. Data from the European Commission shows that in 2025, approximately 5.9 billion low-value e-commerce goods entered the EU, yet only 387,588 customs interventions occurred regarding product conformity. This equates to one intervention per roughly 15,400 items. The ZVA urges authorities to allocate adequate resources for targeted test purchases and improved traceability through product labeling, noting that new customs regulations effective since July 2026 and mandatory product identifiers starting November do not fully replace actual safety compliance checks.
A federal judge in California has certified a class action lawsuit against Hubble Contacts, allowing more than 95,500 California customers to pursue claims that the online contact lens subscription service sold lenses different from those prescribed by their eye doctors. The case, Africa v. Vision Path Inc., alleges Hubble exploited its prescription verification process to substitute its own one-size-fits-all lenses for doctor-prescribed brands. Plaintiffs claim misleading website statements and failed disclosures during checkout exposed consumers to potential eye injuries. The complaint also names co-founders Benjamin Cogan and Jesse Horwitz in a separate fraud conspiracy claim. This certification does not determine liability but enables collective pursuit of claims. Hubble previously paid $3.5 million in 2022 to resolve similar federal allegations.
The Dutch consumer association Consumentenbond has filed a lawsuit seeking to compel Meta to modify Ray-Ban Meta glasses to comply with privacy laws. The primary demand is for changes to default settings and an end to alleged unlawful data processing for AI within two weeks of a favorable ruling. If Meta declares compliance impossible, the group requests a ban on selling the camera-equipped glasses in the Netherlands, excluding cases of medical necessity for blind or partially sighted users. The claim centers on bystander privacy, arguing that recording indicators are insufficiently visible and can be covered. A hearing is scheduled for November 26, 2026, at the Amsterdam district court. Meta has not publicly responded to the current filing.
Austria's Federal Administrative Court overturned a Vienna education authority's decision to exclude a pupil from school for wearing Ray-Ban Meta Wayfarer Gen 2 Custom smart glasses. The judgment, decided on August 3, 2026, found that teacher and classmate unease about potential recording was insufficient grounds for expulsion without evidence of concrete serious misconduct or lasting danger. The court noted no proof of recordings but acknowledged suspicion due to the device's capabilities. The pupil had received medical certification requiring the specific glasses. This case marks the third European jurisdiction this year addressing camera glasses, following proposals for bans in Norway and the Netherlands. The court did not rule on whether smart glasses can ever justify exclusion under statutory conditions.
SPECTARIS Consumer Optics and EUROM Optical Industries successfully addressed a conflict in the EU Medical Device Regulation (MDR) that risked forcing eyewear manufacturers into non-compliance. The issue involved EUDAMED registration deadlines preceding the technical feasibility of Master UDI-DI implementation, potentially exposing producers to sanctions for up to 30 months. Following advocacy efforts, the European Commission published an official position paper on July 10 clarifying that manufacturers may register products with Master UDI-DI before mandatory deadlines if technically feasible, but are not required to do so. Alternatively, existing identifiers like GS1 codes remain valid until the specific Master-UDI deadlines: November 9, 2026, for contact lenses and September 2028 for eyeglass frames, lenses, and ready-made readers. This clarification provides essential legal certainty and audit readiness for the optical industry.
The Norwegian government announced plans to introduce a temporary ban on smart glasses, referred to as 'AI glasses' in official bulletins, in various public locations including parks, beaches, museums, shopping malls, and events. Citing privacy concerns regarding non-consensual filming and audio recording, Minister Torgeir Micaelsen stated the measure aims to facilitate thorough investigation and informed debate for lasting regulation. The proposal is not an outright ban; devices remain permitted for private use and in certain other contexts. Potential extensions under consideration include schools, health institutions with changing rooms, and universities. A special council will examine permanent national regulation of wearable technology. This move follows similar restrictions in US states and cities and sales halts by Dutch retailer Hans Anders due to privacy issues.
The Union of Chambers and Commodity Exchanges of Turkey (TOBB) has distributed a draft guideline to relevant chambers, seeking industry feedback by October 8, 2026. This draft aims to specify implementation details for the July 3, 2026 regulation change, which restricts consumer-facing online contact lens sales to licensed optician websites with valid prescriptions. The proposed guidelines mandate that sales occur only through a single authorized domain name, explicitly prohibiting orders via social media or electronic marketplaces. Key provisions include strict prescription verification before order approval, product traceability requirements involving ÜTS obligations, and bans on misleading health claims or false discounts. Entities holding pharmacy licenses but lacking separate optician permits are excluded from this online sales authorization. The final text may change after the consultation period.
On July 28, 2026, The Vision Council announced guidance for the optical industry regarding new Section 301 tariffs imposed by the Trump Administration on 60 economies. These duties replace expired Section 122 tariffs and include a 12.5% rate on major sourcing markets like China, Vietnam, Thailand, and Cambodia, and a 10% rate on India and Indonesia. The Council advises that the new 12.5% duty on Chinese goods stacks with existing Section 301 rates (7.5% or 25%) rather than superseding them. Traditional eyewear HTS codes do not qualify for exemptions. Additionally, a separate 25% Section 301 duty effective July 22 applies to Brazilian optical products. A proposed 50% penalty on Canadian goods has not yet taken effect. The Council offers a Tariff Dashboard for members to model cost impacts.
Editorial relevance: The Vision Council provides critical guidance on new Section 301 tariffs affecting optical imports, highlighting duty stacking risks and exemption limitations for eyewear products.